Multi-site clinical assessment of Complete Revitalens MPDS in 2981 contact lens wearers across Europe and USA

(MPDS), Complete Revitalens (RevitaLens OcuTec in the US Market), for soft contact lens care in a large “real practice” setting. Method: This is an international multi-center, open-label assessment carried out in 10 countries across Europe and in the USA. Up to 10 subjects who were currently wearing soft contact lenses for at least 1 year and using a MPS as a lens care system were included at each investigational site. Results: Data were collected from 996 European and 1985 American wearers, 75% of those patients wore silicone hydrogel contact lenses. Approximately 94% found the new MPDS “somewhat more effective” to “much more effective” in keeping contact lenses feeling clean and 88% found the new MPDS to be somewhat more effective to much more effective in keeping their lenses feeling comfortable in the evening. Over 93% reported an improvement in vision clearness in the evening after approximately 1 month while using the new MPDS. Wearers with grade 2, 3 or 4 of severity decreased by 11.3, 6.4 and 9.8% over 1 month period for redness, burning and irritation, respectively. After approximately 1 month 83% of wearers declared that they would prefer to use the new MPDS. Conclusions: Over 88% felt their lenses were somewhat to much more comfortable at the end-of-day and 94% found the new MPDS to be somewhat to much more effective in keeping their lenses feeling clean compared to their previous care system.The authors wish to thank the eye care practitioners participating in this study across Europe and USA. The D'Ellis Group for the statistical support and Rafael Guerrero and Will Heydorn from Abbott Medical Optics, Inc. for their contributions in planning and coordinating the European and American branches of the study, respectively. The authors declare no proprietary or financial interest in any of the materials mentioned in this article. This study has been sponsored by Abbott Medical Optics Inc. These results were presented to the American Academy of Optometry Boston, 12-15th, 2011